Home/ Stocks/ PYPD

PolyPid Ltd. Ordinary Shares

PYPD XNAS

$4.38 -0.05 (-1.24%) ▼ 15-min delayed

Open

$4.39

High

$4.47

Low

$4.32

Volume

34.0K

Market Cap

$83.58M

About PolyPid Ltd. Ordinary Shares

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Employees: 75 Website →

Related Market News

No specific coverage for PYPD yet. Check out our latest market news or earnings calendar.

Get PYPD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on PolyPid Ltd. Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.